New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.

Alexia Alexandraki,Elisavet Papageorgiou, Marina Zacharia,Kalliopi Keramida,Andri Papakonstantinou,Carlo M Cipolla,Dorothea Tsekoura,Katerina Naka,Ketti Mazzocco,Davide Mauri,Manolis Tsiknakis,Georgios C Manikis,Kostas Marias,Yiola Marcou,Eleni Kakouri, Ifigenia Konstantinou,Maria Daniel, Myria Galazi, Effrosyni Kampouroglou,Domen Ribnikar,Cameron Brown,Georgia Karanasiou,Athos Antoniades,Dimitrios Fotiadis,Gerasimos Filippatos,Anastasia Constantinidou

Cancers（2023）

引用 0|浏览31

暂无评分

摘要

We highlighted the new insights associated with the use of currently available biomarkers as a standard of care for the management of CTRCD and identified potentially novel clinical biomarkers that could be further investigated as promising predictors of CTRCD.

查看译文

关键词

chemotherapy-induced cardiotoxicity, cancer therapy-induced cardiac dysfunction, clinical biomarkers, breast cancer, LVEF, BNP, troponins

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要